A Turning Point in ALS Trials
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
A Turning Point in ALS Trials
-
Narrated by:
-
By:
About this listen
To drive a turnaround in trials for ALS and other neurological diseases, we at Modality advocate for new tools that increase understanding of the course of disease and response to treatment. Together with MGH, Everything ALS, and, more recently, Verge Genomics, Modality’s platform is building the most comprehensive audio/visual dataset of people living with ALS. In this 45-minute call, we discuss advancements in digital endpoints in clinical trials and the potential to accelerate clinical research. Our special guest is Karl Kieburtz, MD, MPH, Co-Founder and Chair of Clintrex and principal investigator for numerous multi-center trials in neurology.
What listeners say about A Turning Point in ALS Trials
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.